Blue Horseshoe Stocks: Special Report on PZOO


Pazoo, Inc. PZOO

PZOO is the new item of interest that we are introducing this morning, a stock that is going to be a long-term point of focus for us. While we do like where PZOO stands with regard to the chart, it’s the interesting mix of things the company has its hands in that is really grabbing our attention.

For starters, Pazoo runs and is continuously developing a health and wellness network for people and pets (website found at pazoo.com). Through this online portal the company markets targeted information, services, and products which promote healthy living for both people and animals.

In addition to the website, which reportedly receives up to 3 million visitors per month on average, the company has launched Pazoo TV & Radio in order to maximize its exposure to the consumer. Pazoo is referring to 2014 as its “Transformative Year” with regard to its aggressive growth strategy for its network portals.

We learned about a lot of the intriguing aspects of PZOO with the inception of Pazoo Radio; refreshingly, the podcast is hosted by CEO David Cunic himself, which really demonstrates a commitment to transparency, and shows that Pazoo’s leader is a hands-on sort of individual. Currently it’s slated to be a 4-times monthly report; certain shows for delving into health and wellness with industry experts, and other for general status updates on the company.

In addition to its focus on health and wellness, PZOO owns a majority share of MA & Associates, which operates in an interesting cannabis sector niche; the firm conducts medical cannabis testing in Nevada. We’ve seen many businesses profiting off of the increasing acceptance and adoption of medical marijuana, but this is the first we’ve run across that is actually contributing to the quality control of the substance, and by extension, the safety of those who use it. This offshoot project is a good example of the diversification of Pazoo, and is one of the reasons why we want to stick around to watch this story develop.

What’s more, the company has an aggressive outreach planned as it will be sending attendees to several key upcoming conferences, such as the International Cannabis Expo in New York City and the Florida Marijuana Conference. It has also secured a booth at the 3rd Annual Marijuana Business Conference & Expo in Las Vegas coming up on November 12-14th which should really serve to crank up awareness within the sector.

So, as we said, PZOO certainly has some interesting happenings at present, and on top of that, it also has a chart that we can get excited about:

The PPS is currently at a relative bottom, and as we point out below, has a history of recent support at these levels. The stock has been challenging the 50DMA, and other signs seem to indicate that we could be in for a pop in the near future. This is certainly a play that has the potential to run, as evidenced by the huge spike from .02-.05 it exhibited barely a month ago. PZOO qualifies as one to watch in many ways. Moving ahead, we’ll be sure to keep everyone updated on the progress of this promising play.

RECENT HEADLINES:

For More Info on PZOO Visit:
PAZOO.COM
On Twitter: @Pazoo_Inc

Blue Horseshoe Stocks: Recap of Friday’s Winners

Friday in Review

Good Morning Traders! Today’s a big day for us- we’ve got an interesting new pick coming out in about an hour, so we wanted to take this opportunity to review a couple of plays from Friday’s newsletter that gave standout performances.

iBio, Inc. IBIO

IBIO continued to deliver in what was ultimately a great week for the stock. On Friday we saw this play run from a low of 2.06 to as high as 3.48 toward the end of the session. Congratulations to anyone who took advantage of this 69% rip.

ITT Educational Services, Inc. ESI

ESI managed an early morning spike from 6.97-11.75, affording traders the chance at up to 68% in intraday gains. The move came on roughly 13X the 3-month average volume.

Don’t forget to surf back here prior to the open to catch our special report on a new play we don’t think you’ll want to miss -OR- Quickly sign up for our daily pre-market alerts and the report will be delivered straight to your inbox in about an hour.

Blue Horseshoe Stocks: VSR, IBIO & More

Versar, Inc. VSR

VSR continued to play the role of this week’s most interesting pick on Thursday. The action in this play has been significant, and it has led to several potentially profitable swings since we first picked it up on Tuesday at a low of 3.70.

Yesterday we re-iterated our interest, stating that the kind of volatility we had seen in VSR to that point could certainly lead to further bounce opportunities, and we were correct in that assumption. In early trading, we witnessed a swing from 6.56 to the daily high of 7.817, a 19% move. We then watched as VSR spent a good portion of the afternoon in pullback mode before bouncing off of support at in the 5.20’s.

The stock is up in premarket trading again today with highs of over $6 so far, so for the fourth straight day we’ll have our eye on possible bounce action from VSR


Eagle Bulk Shipping EGLE

We tagged EGLE yesterday morning on the heels of a financial restructuring that led to a serious boost in PPS. The stock was up so much in fact, it was briefly halted early in the session. When trading resumed at 11AM, the stock still went on to make one heck of a move.

From an initial low of 12.02, the EGLE barreled its way up to a high of 17.00, a solid 41% increase on the day on significantly high volume.


iBio, Inc. IBIO

IBIO is a play that we’ve been tracking for some time, and it too posted a notable swing yesterday afternoon, as it rose up from 1.63 to touch 1.93, an 18% increase. The stock is also gapping up in the premarket this morning, having re-breached the $2-mark.


Repros Therapeutics, Inc. RPRX

This is a stock we caught this morning, noticing that it is gapping down 52-week lows in the pre-market. The company had some negatively received FDA news this morning. This kicks in our ‘vulture’ mindset, where we monitor a struggling play for signs of a turnaround and subsequent bounce. We can’t even begin to recall how many times we’ve turned a beaten-down stock into a winning trade on the rebound but rest assured, its enough for us to keep a close watch over RPRX moving forward.


Extended Watchlist:
APT, CYTR, ESI, AKS